Drospirenone, a New Progestogen, for Postmenopausal Women with Hypertension

@article{Mallareddy2007DrospirenoneAN,
  title={Drospirenone, a New Progestogen, for Postmenopausal Women with Hypertension},
  author={M. Mallareddy and V. Hanes and W. White},
  journal={Drugs \& Aging},
  year={2007},
  volume={24},
  pages={453-466}
}
The prevalence of hypertension increases in women after the menopause. Associated with the rise in postmenopausal blood pressure (BP) are increased salt sensitivity and imbalance between the renin-angiotensin-aldosterone system and nitric oxide pathways that lead to sodium and water retention. Drospirenone is the first synthetic progestogen with antialdosterone activity similar to natural progesterone. Drospirenone counteracts the salt- and water-retaining effects of estrogen and causes… Expand
The “newer” progestogens and postmenopausal hormone therapy (HRT)
  • A. Schindler
  • Biology, Medicine
  • The Journal of Steroid Biochemistry and Molecular Biology
  • 2014
Novel therapeutic targets for hypertension
New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation
  • R. Sitruk-Ware
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2007
Cardiovascular Risk During the Menopause
Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies.
  • A. Boldo, W. White
  • Medicine
  • Endocrinology and metabolism clinics of North America
  • 2011
Mineralocorticoid receptor haplotype moderates the effects of oral contraceptives and menstrual cycle on emotional information processing
...
1
2
3
...

References

SHOWING 1-10 OF 59 REFERENCES
...
1
2
3
4
5
...